Deutsche Bank Ag\ Talaris Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.09 - $2.09 $5,872 - $11,260	5,388 Added 61.46%	14,154 $26,000
Q4 2022 Feb 13, 2023	BUY	$0.94 - $1.64 $145 - $254	155 Added 1.8%	8,766 $8,000
Q3 2022 Nov 14, 2022	SELL	$2.3 - $5.03 $3,438 - $7,519	-1,495 Reduced 14.79%	8,611 $23,000
Q2 2022 Aug 11, 2022	SELL	$4.51 - $9.85 $6,620 - $14,459	-1,468 Reduced 12.68%	10,106 $46,000
Q1 2022 May 13, 2022	SELL	$6.89 - $16.56 $9,508 - $22,852	-1,380 Reduced 10.65%	11,574 $114,000
Q4 2021 Feb 11, 2022	BUY	$12.18 - $17.0 $93,469 - $130,458	7,674 Added 145.34%	12,954 $198,000
Q3 2021 Nov 04, 2021	SELL	$11.61 - $15.99 $92 - $127	-8 Reduced 0.15%	5,280 $72,000
Q2 2021 Aug 11, 2021	BUY	$12.25 - $18.61 $64,778 - $98,409	5,288 New	5,288 $78,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.